Search research articles
Contact Us
Filters
Showing results (71-80 of 79) with videos related to
Page
of 8
Sort By:
You have reached the last page of results.
This site can display upto 79 results.
Life Sciences
|
November 13, 2002
SR 142801, a tachykinin NK(3) receptor antagonist, prevents beta(2)-adrenoceptor agonist-induced hyperresponsiveness to neurokinin A in guinea-pig isolated trachea
F M Pinto, J-P Saulnier, C Faisy, et al.
Targeted Oncology
|
December 25, 2012
Treatment of advanced gastrointestinal stromal tumors in patients over 75 years old: clinical and pharmacological implications
A Italiano, E Saada, A Cioffi, et al.
Respiratory Medicine and Research
|
December 16, 2020
The determinants of dyspnoea evaluated by the mMRC scale: The French Palomb cohort
E H Ouaalaya, L Falque, J M Dupis, et al.
British Journal of Cancer
|
October 24, 2013
A dose-escalating phase I of imatinib mesylate with fixed dose of metronomic cyclophosphamide in targeted solid tumours
A Adenis, I Ray-Coquard, A Italiano, et al.
Leukemia
|
November 30, 2012
Rapid mobilization of cytotoxic lymphocytes induced by dasatinib therapy
S Mustjoki, K Auvinen, A Kreutzman, et al.
The European Respiratory Journal
|
June 14, 2014
Integrated care pathways for airway diseases (AIRWAYS-ICPs)
, , , et al.
Allergy
|
July 7, 2015
MACVIA-ARIA Sentinel NetworK for allergic rhinitis (MASK-rhinitis): the new generation guideline implementation
J Bousquet, H J Schunemann, J Fonseca, et al.
Clinical and Translational Allergy
|
August 2, 2016
Scaling up strategies of the chronic respiratory disease programme of the European Innovation Partnership on Active and Healthy Ageing (Action Plan B3: Area 5)
J Bousquet, J Farrell, G Crooks, et al.
Clinical and Translational Allergy
|
February 28, 2017
Erratum to: Scaling up strategies of the chronic respiratory disease programme of the European Innovation Partnership on Active and Healthy Ageing (Action Plan B3: Area 5)
J Bousquet, J Farrell, G Crooks, et al.
Page
of 8
Search research articles
Search
Showing results (71-80 of 79) with videos related to
Sort By:
Page
of 8
You have reached the last page of results.
This site can display upto 79 results.
Life Sciences
|
November 13, 2002
SR 142801, a tachykinin NK(3) receptor antagonist, prevents beta(2)-adrenoceptor agonist-induced hyperresponsiveness to neurokinin A in guinea-pig isolated trachea
F M Pinto, J-P Saulnier, C Faisy, et al.
Targeted Oncology
|
December 25, 2012
Treatment of advanced gastrointestinal stromal tumors in patients over 75 years old: clinical and pharmacological implications
A Italiano, E Saada, A Cioffi, et al.
Respiratory Medicine and Research
|
December 16, 2020
The determinants of dyspnoea evaluated by the mMRC scale: The French Palomb cohort
E H Ouaalaya, L Falque, J M Dupis, et al.
British Journal of Cancer
|
October 24, 2013
A dose-escalating phase I of imatinib mesylate with fixed dose of metronomic cyclophosphamide in targeted solid tumours
A Adenis, I Ray-Coquard, A Italiano, et al.
Leukemia
|
November 30, 2012
Rapid mobilization of cytotoxic lymphocytes induced by dasatinib therapy
S Mustjoki, K Auvinen, A Kreutzman, et al.
The European Respiratory Journal
|
June 14, 2014
Integrated care pathways for airway diseases (AIRWAYS-ICPs)
, , , et al.
Allergy
|
July 7, 2015
MACVIA-ARIA Sentinel NetworK for allergic rhinitis (MASK-rhinitis): the new generation guideline implementation
J Bousquet, H J Schunemann, J Fonseca, et al.
Clinical and Translational Allergy
|
August 2, 2016
Scaling up strategies of the chronic respiratory disease programme of the European Innovation Partnership on Active and Healthy Ageing (Action Plan B3: Area 5)
J Bousquet, J Farrell, G Crooks, et al.
Clinical and Translational Allergy
|
February 28, 2017
Erratum to: Scaling up strategies of the chronic respiratory disease programme of the European Innovation Partnership on Active and Healthy Ageing (Action Plan B3: Area 5)
J Bousquet, J Farrell, G Crooks, et al.
Page
of 8